Evokai Creative Labs Inc. (OKAI)
Market Closed
10 Aug, 20:00
TSX-V 
OTCQB Primary TSX-V CA$
0. 12
0
0%
CA$
874.63K Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
CA$ 0.12
Previous Close Want to track OKAI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
OKAI closed today higher at CA$0.12, an increase of 0% from yesterday's close, completing a monthly increase of 0% or CA$0. Over the past 12 months, OKAI stock gained 0%.
OKAI is not paying dividends to its shareholders.
The last earnings report, released on Feb 23, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Evokai Creative Labs Inc. has completed 3 stock splits, with the recent split occurring on Feb 05, 2025.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on OTCQB (USD).
Evokai Creative Labs Inc. (OKAI) FAQ
What is the stock price today?
The current price is CA$0.12.
On which exchange is it traded?
Evokai Creative Labs Inc. is listed on TSX-V.
What is its stock symbol?
The ticker symbol is OKAI.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 874.63K.
Has Evokai Creative Labs Inc. ever had a stock split?
Evokai Creative Labs Inc. had 3 splits and the recent split was on Feb 05, 2025.
Evokai Creative Labs Inc. Profile
| Technology Hardware, Storage & Peripherals Industry | Information Technology Sector | Mr. Alejandro Antalich CEO | TSX-V Exchange | CA30053J2002 ISIN |
| US Country | - Employees | - Last Dividend | 5 Feb 2025 Last Split | - IPO Date |
EvokAI Creative Labs Inc., a MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector. The company's artificial intelligence-enhanced diagnostic profiles provide a basis to monitor mental wellbeing and enable advances in medical diagnoses. It deploys machine learning models to search medical data, integrate novel medical devices, and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide accurate diagnoses. The company also provides EvokAI Simulators, which combine cognitive neuroscience, virtual reality (VR), and AI technologies to assess cognitive performance and spatial perception; EvokAI Movement Disorder Monitor (MDM) Basic, a wireless and real-time monitor that accurately analyzes the magnitude of movement disorders and the effectiveness of treatments for Parkinson´s disease and other movement disorders, such as dystonia, various diseases causing tremors, Tourette´s syndrome, congenial CP, or MS; and EvokAI MDM PRO, which is used to monitor movement disorders in real time for the accurate surgical results. In addition, it offers EvokAI Neurotrainer, which provides brain health solutions for various ages; and EvokAI Medical, which offers mental wellbeing through AI-driven digital solutions. The company is headquartered in Vancouver, Canada. EvokAI Creative Labs Inc. is a subsidiary of Union Acquisition Group, LLC.
Contact Information
Address: 609 Granville Street, Vancouver, BC, Canada, V7Y 1C3
Phone: -
Website: https://www.evokailabs.com
